CURRENT ACADEMIC ROLE & RESPONSIBILITIES
- Consultant and clinician in Department of Neurology dealing with inpatient and outpatient care and emergency care services
- Reporting of Neuroelectrophysiology tests (EEG, Nerve conduction studies, EMG)
- Teacher to undergraduate and post graduate students including Neurology residents.
- Quality Coordinator for department of Neurology.
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| MBBS | Bachelor | Mysore Medical College, Mysore | March 2004 |
| MD | General Medicine | Karnataka Institute of Medical Science, Hubli | March 2009 |
| DM | Neurology | St. John’s Medical College, Bengaluru | March 2014 |
| MRCP SCE | NEUROLOGY | Royal College of Physicians , United Kingdom | 2020 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Kasturba Medical College, 365体育投注 | Professor | March 2023-Till date | |
| Kasturba Medical College, 365体育投注 | Associate Professor | September 2019- March 2023 | |
| Kasturba Medical College, 365体育投注 | Assistant Professor | July 2016- September 2019 | |
| St. Johns Medical College | Assistant Professor | Sep 2014 to July 2016 | |
| Fr. Muller Medical College, Mangalore | Assistant Professor (Department of Medicine) | June 2010 to July 2011 | |
| PESIMSR, Kuppam, Andhra Pradesh | Assistant Professor (Department of Medicine) | June 2009 to June 2010 |
FeSSH Stroke Trial
Principal investigator: Dr. Aparna R. Pai
Co-investigator: Dr. Arvind N. Prabhu
Funding agencies: ICMR
A randomized, double-blind, multicenter, placebo-controlled phase 3 study with open-label period to evaluate the efficacy and safety of inebilizumab in adults with myasthenia gravis (MINT)
Principal investigator: Dr. Arvind N. Prabhu?
Co-investigator: Dr. Nisha Shenoy, Dr. Nikith A.
Funding agencies: Viela Bio, Inc, One MedImmune Way, Gaithersburg, MD 20878 USA
Enhanced control of hypertension and thrombolysis stroke study (ENCHANTED) trial (2017-2018). The Lancet 2019: 393: 877-888.
Co-investigator in Enhanced control of hypertension and thrombolysis stroke study (ENCHANTED) trial (2017-2018). The Lancet 2019: 393: 877-888
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Stroke, Neuromuscular diseases, Movement disorders, Neuroimmunology/Autoimmune disease and Headache
Area of Expertise
Acute stroke care management & Intravenous thrombolysis
Area of 365体育投注
Special interest in Parkinsonism and Parkinson’s disease research.